Atlas Trials

Assessment of the Impact of Oral Intervention With Cetylpyridinium Chloride to Decrease SARS-CoV-2 Viral Load in Patients With COVID-19

Clinical trial NCT04820803 · COMPLETED

Trial details

NCT number
NCT04820803
Sponsor
Rosa Tarrago
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
COVID-19SARS-CoV-2 Infection
Start date
2021-02-03
Primary completion
2021-04-29
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.